Biopharma Valuation

Introduction

Who should attend

Feature

Core Learning Area

Related Courses

This online training course provide understanding of valuation techniques that are commonly applied in the pharma and biotech industries.

This course provides comprehensive skill training for business development managers working in biopharmaceutical industry. Biopharma Valuation course covers biopharmaceutical business and brand valuation tools and techniques. Moreover course provides hands on training on biopharma business development deal identification, valuation and strategic planning process.

In these online self-paced modules, participants also understand about how to do forecasting of the early stage compounds. In other words, you will understand how effectively how to do valuation for discovery stage compounds. Moreover, this course focuses on how to devise and plan royalty in biopharma deal. Therefore, it helps advance professionals to acquire cutting edged business skills.

Self Paced Learning

This course utilizes interactive learning tools to guide participant to understand of the brand valuation process in biopharmaceutical business atmosphere. The course will focus on understanding business development skills which is required for effective functioning as BD personnel in business development department. This online training will adopt a practical and interactive approach that will enable you to apply what you have learned to your daily work. The steps of approval process in details. The course will challenge the students to apply what they have learned through the use of interactive exercises, reflection questions, simulation and a final assessment at the end of the course.

This bio pharmaceutical business development course provide detailed training on biopharma valuation tools and techniques.

The course can be completed at any pace, allowing the user to stop and start at their leisure.

Title of the course: Advanced Certification in Biopharma Valuation
Course Code: RYD-037
Type of the course: Self paced Online Course
Duration: 1 Month
Certification: Course certificate will be issued on completion of the course.

Who should attend this course?

This course is ideal for those who are working in business development and licensing department.
Professionals from strategic management. Those working in strategic management department in pharmaceutical and biopharmaceutical company.
Most importantly this course provides valuable insight to those who are working on early stage discovery project and want hands on training on valuating discovery stage compounds.
Those who are in the regulatory affairs and related department, and looking for change into business development department.
This biopahrma valuation management course is ideal for the senior management professionals working in pharmaceutical and biopharmaceutical project management.
Anyone requiring an overview and detail understanding on working of IPR, Inlicensing, Outlicensing and Technology Transfer Department.

Online 24×7 access from anywhere. Hence, one can learn at your convenience.
The course provides timing flexibility. In other words, one can attend the lecture sessions at your own convenient time.
The course is build on interactive e-learning. Hence, it helps user to understand of the concepts effectively.
Above all, course provides simulation for real life working. Hence, it helps user to apply the decision making skill in real life scenarios.

Core Learning Areas in Biopharma Valuation Training

Scope and agenda development for the course.
Introduction to assessing company and valuation
Fundamental understanding on Return on investment (ROI)
Risk vs. return
Valuation Model for – Pharmaceutical and Biopharmaceutical companies
Focus on the most used company valuation methods
Discount Cash Flows
Market / Deal comparable
Case based understanding on valuation
Difference between company valuation and product valuation
Concept of DCF, CCA, Terminal Value, Net Present Value (NPV) Vs. Risk-adjusted Net Present Value (rNPV)
Benchmarking
How to calculate the value of a company from several product valuations
Deal Structuring
upfront payment
Milestone payments
Royalties

Some of the related courses

Section 1Fundamental of Biopharma Valuation : Identify, Profiling, Valuation of Early stage assets

Lecture 1Pharma R&D Process & Introduction to drug discovery

Lecture 2Business Development Job Functionality | Strategic Planning Process | Knowledge Area of Business Development | Lead targeting | Licensing term sheets

Lecture 3Portfolio Management Process | Portfolio Characteristics | Portfolio Analysis | Balancing the Portfolio | BD and Strategic Planning Department

Lecture 4Identifying the corporate Need of business development | Objective – Strategy - Tactics | Portfolio constraints | SWOT | Numerical SWOT

Lecture 6Numerical SWOT Practical training

Lecture 7Types of Deal from Drug Discovery to Commercialization

Lecture 8Training on Basic Finance | Understanding Financial Statement | Income Statement | Balance Sheet | Cash Flow Statement

Lecture 9Orientation on Biopharma Market Access

Lecture 11Economic Evaluation Methods | Various methods | Importance of perspective in health economics | Discounting | Uncertainty

Lecture 13QALY | How to calculate QALY | Importance and Significance

Lecture 14ICER | How to calculate ICER | Importance and Significance | Incremental Effectiveness determination

Lecture 18Pharmaco-economic evaluation – analysis and results | Different Types of Models | Understanding Decision Tree - Components with practical Example | Markov model

Lecture 19CER and PCOR

Section 2Forecasting

Lecture 20New Product Forecast Algorithm

Lecture 21Patient Based Forecasting Model | Applying more filters and variables

Lecture 22Prescription Based Forecasting Model | Differences between Patient Based and Prescription Based Forecasting Model | Which model to use and when?

Lecture 23Prevalence Vs. Incidence Model

Lecture 24EPI Based Forecasting | Sales Based Forecasting | When and where to apply which forecasting model

Lecture 25Sales Forecasting Tools | New Product Forecasting | In Market Forecasting

Lecture 26Market Size Assignment 1 [Oncology Brand] - Applying sales forecasting tools to carry out next 6 years sales forecast | Excel Based Model

Lecture 27Market Size Assignment 2 [Asthma Brand] - Applying sales forecasting tools to carry out multiple years sales forecast | Excel Based Model

Lecture 28Patient Based Model Vs. Patient Flow Model | Critical Differences in Model | Concept of Black Box in Patient Flow Model | Application of both model

Lecture 29Bottom-up or Top-down Forecasting | LRx | Significance of LRx data analysis

Lecture 30Simulation on Bottom-up forecasting

Lecture 31Assessment on Bottom-up forecasting

Lecture 32Portfolio Based Forecasting | Forecasting Model Development in Excel

Section 3Valuation

Lecture 35Average Royalty Rate

Lecture 36Factor affecting the Royalty Rate in Pharmaceutical and Biopharmaceutical Deal

Lecture 37Factors affecting royalty rate

Lecture 40Licensing Term Sheet | Content Structuring | Sample Term Sheet

Lecture 41Licensing Payment Schedule | Case Study

Lecture 43Valuation Methods: EBITDA method of valuation | Enterprise Value and Enterprise Multiple Calculation

Lecture 44Business Development Simulation and Decision Making | Early Stage VS. Late Stage Valuation Methodology | Stair Step Model

Lecture 46Value Share Principle | Discounting of licensing deal | Discount Rate

Lecture 47DCF Calculation : Concept and Calculation - Step by step understanding

Lecture 48Net Present Value (NPV) method : Calculation

Lecture 49Risk-Adjusted Discount Rate Method - Calculation | Concept of Risk Premium

Lecture 50Valuation Metric - P/E Ratio and EPS : Calculation

Lecture 51Comparable Company Analysis method : Calculation

Lecture 52Benchmarking | Benchmarking through consortium | How to use benchmarking for drug discovery development projects

Lecture 53WACC in Biopharma Valuation | Significance | WACC benchmarking

Lecture 54WACC Calculation | Step by Step Calculation | Insight on WACC components

Lecture 55rNPV Model | Step by Step Calculation | Insight on Probability and Cumulative Probability | Factoring WACC for Discounting

Lecture 56Probability and Cumulative Probability | Calculation | Benchmarking | Factoring for WACC and rNPV

Lecture 57Real Options Valuation (ROV) for Biopharma assets | Model Development | Calculation | Case Based Insight in the context of inlicensing and outlicensing | Early stage asset valuation with ROV

Lecture 58ROV Scenario Based Case Study

Lecture 59Biotech Decision Tree Model with Decision Reasoning